141 related articles for article (PubMed ID: 32260323)
1. Elaboration of Charged Poly(Lactic-co-Glycolic Acid) Microparticles for Effective Release of Tranexamic Acid.
Huang MH; Huang SY; Chen YX; Chen CY; Lin YS
Polymers (Basel); 2020 Apr; 12(4):. PubMed ID: 32260323
[TBL] [Abstract][Full Text] [Related]
2. Encapsulation of Nicardipine Hydrochloride and Release from Biodegradable Poly(D,L-lactic-co-glycolic acid) Microparticles by Double Emulsion Process: Effect of Emulsion Stability and Different Parameters on Drug Entrapment.
Soomherun N; Kreua-Ongarjnukool N; Chumnanvej S; Thumsing S
Int J Biomater; 2017; 2017():1743765. PubMed ID: 29250113
[TBL] [Abstract][Full Text] [Related]
3. Characterization of PLGA microparticles as a drug carrier for 3-ethoxycarbonyl-2h-benzofuro[3,2-f]-1-benzopyran-2-one. Ultrastructural study of cellular uptake and intracellular distribution.
Gomes AJ; Faustino AS; Machado AE; Zaniquelli ME; de Paula Rigoletto T; Lunardi CN; Lunardi LO
Drug Deliv; 2006; 13(6):447-54. PubMed ID: 17002973
[TBL] [Abstract][Full Text] [Related]
4. Formulation and characterization of poly(propylacrylic acid)/poly(lactic-co-glycolic acid) blend microparticles for pH-dependent membrane disruption and cytosolic delivery.
Fernando LP; Lewis JS; Evans BC; Duvall CL; Keselowsky BG
J Biomed Mater Res A; 2018 Apr; 106(4):1022-1033. PubMed ID: 29164777
[TBL] [Abstract][Full Text] [Related]
5. Poly(2-propylacrylic acid)/poly(lactic-co-glycolic acid) blend microparticles as a targeted antigen delivery system to direct either CD4
Yang L; Bracho-Sanchez E; Fernando LP; Lewis JS; Carstens MR; Duvall CL; Keselowsky BG
Bioeng Transl Med; 2017 Jun; 2(2):202-211. PubMed ID: 29313030
[TBL] [Abstract][Full Text] [Related]
6. Formation Mechanism, In vitro and In vivo Evaluation of Dimpled Exenatide Loaded PLGA Microparticles Prepared by Ultra-Fine Particle Processing System.
Zhu C; Peng T; Huang D; Feng D; Wang X; Pan X; Tan W; Wu C
AAPS PharmSciTech; 2019 Jan; 20(2):64. PubMed ID: 30627822
[TBL] [Abstract][Full Text] [Related]
7. Comparative studies on exenatide-loaded poly (D,L-lactic-co-glycolic acid) microparticles prepared by a novel ultra-fine particle processing system and spray drying.
Zhu C; Huang Y; Zhang X; Mei L; Pan X; Li G; Wu C
Colloids Surf B Biointerfaces; 2015 Aug; 132():103-10. PubMed ID: 26037698
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor-1 (IGF-1) poly (lactic-co-glycolic acid) (PLGA) microparticles - development, characterisation, and
Hameed A; Gallagher LB; Dolan E; O'Sullivan J; Ruiz-Hernandez E; Duffy GP; Kelly H
J Microencapsul; 2019 May; 36(3):267-277. PubMed ID: 31195912
[No Abstract] [Full Text] [Related]
9. PLGA, chitosan or chitosan-coated PLGA microparticles for alveolar delivery? A comparative study of particle stability during nebulization.
Manca ML; Mourtas S; Dracopoulos V; Fadda AM; Antimisiaris SG
Colloids Surf B Biointerfaces; 2008 Apr; 62(2):220-31. PubMed ID: 18023977
[TBL] [Abstract][Full Text] [Related]
10. Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing.
Witschi C; Doelker E
J Control Release; 1998 Feb; 51(2-3):327-41. PubMed ID: 9685930
[TBL] [Abstract][Full Text] [Related]
11. In vivo evaluation of solid lipid microparticles and hybrid polymer-lipid microparticles for sustained delivery of leuprolide.
Wu C; Luo X; Baldursdottir SG; Yang M; Sun X; Mu H
Eur J Pharm Biopharm; 2019 Sep; 142():315-321. PubMed ID: 31299277
[TBL] [Abstract][Full Text] [Related]
12. Co-delivery of polyinosinic:polycytidylic acid and flagellin by poly(lactic-
Dai X; He J; Zhang R; Wu G; Xiong F; Zhao B
Int J Nanomedicine; 2017; 12():6617-6632. PubMed ID: 28924346
[TBL] [Abstract][Full Text] [Related]
13. Shear Speed-Regulated Properties of Long-Acting Docetaxel Control Release Poly (Lactic-
Zheng Y; Sheng F; Wang Z; Yang G; Li C; Wang H; Song Z
Front Pharmacol; 2020; 11():1286. PubMed ID: 32973517
[TBL] [Abstract][Full Text] [Related]
14. Brush-like branched biodegradable polyesters, part III. Protein release from microspheres of poly(vinyl alcohol)-graft-poly(D,L-lactic-co-glycolic acid).
Frauke Pistel K; Breitenbach A; Zange-Volland R; Kissel T
J Control Release; 2001 May; 73(1):7-20. PubMed ID: 11337055
[TBL] [Abstract][Full Text] [Related]
15. Tunable delayed controlled release profile from layered polymeric microparticles.
Dutta D; Fauer C; Hickey K; Salifu M; Stabenfeldt SE
J Mater Chem B; 2017 Jun; 5(23):4487-4498. PubMed ID: 28652916
[TBL] [Abstract][Full Text] [Related]
16. Electron dispersive X-ray spectroscopy and degradation properties of hyaluronic acid decorated microparticles.
Serri C; Frigione M; Ruponen M; Urtti A; Borzacchiello A; Biondi M; Itkonen J; Mayol L
Colloids Surf B Biointerfaces; 2019 Sep; 181():896-901. PubMed ID: 31382338
[TBL] [Abstract][Full Text] [Related]
17. Modification of biodegradable poly(malate) and poly(lactic-co-glycolic acid) microparticles with low molecular polyethylene glycol.
Yoncheva K; Lambov N; Miloshev S
Drug Dev Ind Pharm; 2009 Apr; 35(4):449-54. PubMed ID: 19288298
[TBL] [Abstract][Full Text] [Related]
18. Lipid and PLGA Microparticles for Sustained Delivery of Protein and Peptide Drugs.
Wu C; Mu H
Pharm Nanotechnol; 2020; 8(1):22-32. PubMed ID: 31663483
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of poly (lactic-co-glycolic acid)-poly ethyleneimine-plasmid DNA microparticles prepared using double emulsion methods.
Zhang XQ; Intra J; Salem AK
J Microencapsul; 2008 Feb; 25(1):1-12. PubMed ID: 18188727
[TBL] [Abstract][Full Text] [Related]
20. MT1-MMP Responsive Doxorubicin Conjugated Poly(lactic-co-glycolic Acid)/Poly(styrene-alt-maleic Anhydride) Core/Shell Microparticles for Intrahepatic Arterial Chemotherapy of Hepatic Cancer.
Davaa E; Lee J; Jenjob R; Yang SG
ACS Appl Mater Interfaces; 2017 Jan; 9(1):71-79. PubMed ID: 27966863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
